My interest was aroused by the statement that the Company would expand into broader Med Tech areas including collaborations and product based acquisitions. I can understand collaborations in relation to the vaccine programs but I don't have a clue on what we may be considering in product based acquisitions. Does anyone have any idea?
My interest was aroused by the statement that the Company would...
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$14.41 |
Change
-0.590(3.93%) |
Mkt cap ! $311.4M | |||
| Open | High | Low | Value | Volume |
| $14.50 | $14.94 | $14.25 | $937.0K | 64.34K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 276 | $14.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.80 | 1402 | 4 |
View Market Depth
| Last trade - 15.41pm 05/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |